1. Home
  2. BCTX

BCTX

BriaCell Therapeutics Corp.

Logo BriaCell Therapeutics Corp.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

Founded: 2014 Country:
Canada
Canada
Employees: N/A City: WEST VANCOUVER
Market Cap: 42.8M IPO Year: N/A
Target Price: $18.00 AVG Volume (30 days): 90.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.68 EPS Growth: N/A
52 Week Low/High: $2.19 - $7.67 Next Earning Date: 03-18-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: